UHC Sainte-Justine

Running trials

• Recruiting

  Silmitasertib (CX-4945) in Combination With Chemotherapy for Relapsed Refractory Solid Tumors

  NCT06541262· Phase 1/2· Source

• Recruiting

  Naxitamab Added to Induction for Newly Diagnosed High-Risk Neuroblastoma

  NCT05489887· Phase 2· Source

• Active, not recruiting

  Eflornithine (DFMO) and Etoposide for Relapsed/Refractory Neuroblastoma

  NCT04301843· Phase 2· Source

• Active, not recruiting

  Neuroblastoma Maintenance Therapy Trial

  NCT02679144· Phase 2· Source

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Childhood cancers2 recruiting
• Neuroblastoma2 recruiting
• Sarcoma1 recruiting

Researchers

No researcher is linked here yet.